Alternative sampling strategies such as dried blood sampling, liquid microsampling and the sampling of oral fluid, hair, meconium, interstitial fluid, sweat, exhaled breath condensate and sputum offer interesting opportunities for many applications in clinical routine. Here, we provide an overview of different applications, with special attention to the pivotal role of LC-MS/MS in facilitating analysis of the collected matrices. Covered clinical fields include newborn screening, endocrinology, therapeutic drug monitoring, phenotyping, toxicology, proteomics and metabolomics. Furthermore, specific advantages, challenges and limitations of each alternative sampling strategy are discussed, along with recent advances and future trends that may contribute to routine implementation of these sampling strategies. Given the development of many recent potentially valuable clinical applications, the possibility of home sampling and the opportunity to obtain information that is hard to procure using traditional sampling, a well-balanced role for alternative sampling strategies can be envisaged in patient healthcare in the (near) future.
INTRODUCTION
Alternative sampling strategies include the collection of 'traditional' samples (blood, plasma, serum or urine) in an alternative way, as well as the collection of 'alternative' samples in all kind of ways. A typical example of the former is the collection of dried blood spots (DBS) (i.e. the collection of blood in an unconventional manner), while examples of the latter include sampling of oral fluid, hair and a wide variety of other matrices. Both the 'alternative sampling' and the 'alternative samples' offer interesting opportunities for clinical applications, as they do not only imply easier sample collection (particularly in special patient populations such as small children and neonates), but can also provide information that is impossible or hard to obtain using traditional sampling strategies, such as venipuncture and urine collection. Moreover, the use of alternative sampling strategies is often coupled to matrix-specific advantages such as increased analyte stability and/or the possibility of home sampling. However, the implementation of alternative sampling strategies in clinical routine requires sensitive analytical techniques, since generally only minute amounts of sample are available and/or low analyte levels may be present. For the quantitative analysis of traditional samples in clinical routine, detection methods such as gas chromatography-mass spectrometry (GC-MS) and particularly immunoassays have been and are still being employed. Over the last decade, a clear trend towards implementing liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) has been observed 1, 2 . Especially in larger clinical laboratories, the added-value of LC-MS/MS has been advocated. Also for the analysis of samples obtained via alternative sampling strategies, LC-MS/MS is the technique of choice when it comes to combining sufficient sensitivity with utmost selectivity.
ALTERNATIVE SAMPLING STRATEGIES
In this review we will focus on the implementation of patient-friendly, minimally or noninvasive alternative sampling strategies which are promising for clinical routine, with special attention to the role of LC-MS/MS. Microsampling of blood to collect liquid microsamples or to generate dried blood or dried plasma spots (DPS), as well as sampling of oral fluid, hair, meconium, interstitial fluid (ISF), sweat, exhaled breath condensate (EBC) and sputum are the alternative sampling strategies covered in this review. While there is a plethora of reports on the use of alternative sampling strategies for research purposes, (pre)clinical and epidemiological studies, we focus here on those methods that are -in our opinion-most promising for application in clinical routine. The different areas in which alternative sampling strategies may have added-value will be highlighted and for each category some key examples will be discussed, without being comprehensive.
One of the best known alternative sampling strategies is DBS sampling. DBS are generally prepared by depositing a drop of capillary blood, obtained by a finger or heel prick, on a filter paper. The application field of DBS is highly diverse, going from newborn screening (NBS, the screening for inborn errors of metabolism), over therapeutic drug monitoring (TDM) to toxicology and pharmacokinetic studies in drug development. Other microsampling approaches closely related to DBS sampling are DPS and liquid microsampling, as well as volumetric absorptive microsampling (VAMS). The latter is performed using a handheld device consisting of a plastic handle and a hydrophilic polymer tip which absorbs a fixed volume of blood (±10 µL). The advantages and challenges posed by (dried) blood microsampling have been subject to many reviews [3] [4] [5] [6] . Briefly, common advantages of dried samples in general include the ease of sampling and the convenient transport and storage under ambient conditions. In addition, these samples pose a reduced risk of infection due to deactivation of pathogens upon drying. In DBS analysis, the hematocrit issue is undoubtedly the most widely discussed challenge. Variations in hematocrit influence the spreading of blood on filter paper, thereby impacting the spot size and, possibly, homogeneity.
Furthermore, hematocrit may also influence recovery and matrix effect. As outlined further (see section 6.1), several approaches have been developed that allow to cope with the issues imposed by varying hematocrit 3, 7, 8 . Aside from the hematocrit effect, DBS analysis is also affected by the volume of blood deposited on the filter paper and the punch location 9 . Another issue, which applies to all microsampling strategies, is the possible difference in concentration between capillary and venous blood.
Liquid microsampling is the sampling of liquid capillary blood using a precision capillary. It is used in the pharmaceutical industry, primarily in the preclinical phase of drug development, to obtain pharmacokinetic and toxicokinetic information, e.g. from laboratory animals. Also in the clinical lab, liquid microsamples (typically taken from children) are already being used, e.g. for hemoglobin A1c (HbA1c) monitoring. As the precision capillaries are filled with liquid blood, immediate analysis or processing (e.g. centrifugation, dilution in a stabilizing buffer and/or freezing) after sampling is generally required, making transport and storage less practical when compared to DBS, DPS and VAMS.
Another widely used alternative matrix is oral fluid. Oral fluid is composed of saliva (an aqueous secretion produced by the major salivary glands), the secrete of the accessory glands, gingival fluid, enzymes, other proteins, electrolytes, bacteria, epithelial cells, ora-nasopharyngeal secretions, and other debris 10 . Although oral fluid, as an alternative to plasma, has arisen as a potential alternative matrix for TDM, the best established oral fluid-based application to date is roadside drug testing. A major concern coupled to oral fluid analysis, is the risk of contamination. Indeed, contamination with food and/or beverages, other debris from the mouth or smoke are commonly seen 11 . In addition, oral fluid analysis is also prone to oral contamination. Therefore, sampling should be performed immediately before drug intake or after an adequate 'wash-out' period 12 . Furthermore, blood contamination of the oral fluid caused by leakage from the oral mucosa as a result of microinjuries, such as burns or abrasions and due to gingivitis and periodontitis or even following regular mouth hygiene, might compromise analyte quantitation in oral fluid. The latter can have a major impact on the analysis of compounds with a blood to oral fluid ratio which strongly deviates from 1, as was demonstrated for the measurement of e.g. salivary cortisol and testosterone [13] [14] [15] . Another important issue in oral fluid analysis is the fact that analyte levels may depend on a multitude of variables such as compound pKa, molecular weight, charge and lipid solubility, as well as oral fluid pH, flow rate and metabolism 10, 16 . Consequently, the measured oral fluid concentrations can be heavily influenced by the employed collection procedure 16, 17 . Oral fluid can either be collected without stimulation (e.g. via passive drooling) or with mechanical or chemical stimulation (e.g. by chewing on paraffin or by using citric acid, respectively) 16, 17 .
Moreover, adsorption may occur to collection devices and -important when sample analysis is to be performed by LC-MS/MS-matrix effects may arise from incorporated buffers, preservatives or surfactants [16] [17] [18] . Due to the above-mentioned issues, careful selection and standardization of the oral fluid collection procedure is essential to obtain reliable and reproducible results.
The most important advantage of hair sampling is undoubtedly the wider window of detection, due to the fact that incorporated compounds are no longer subject to biotransformation. However, substances of interest can gradually leach out of the hair or can be removed to an important extent by hair damaging caused by cosmetic treatment, such as bleaching or dyeing, resulting in an underestimation of exposure or use 19 . Other advantages are the non-invasive nature of the sampling and the fact that the collection of a hair sample does not pose any privacy issues. However, it needs to be mentioned that hair sampling can be considered somewhat intrusive. One of the main challenges in hair analysis is external contamination or passive drug exposure. Therefore, a decontamination step is an essential factor in hair analysis, although also the decontamination itself poses challenges, as outlined in section 4 [20] [21] [22] .
Sweat, having a detection or collection window that may range from 30 minutes up to 1-2 weeks, is commonly collected using transdermal absorptive sweat patches, typically applied to the back, upper arm or lower chest and generally worn for several days. While the measurement of chloride in sweat for diagnosis of cystic fibrosis is likely the best studied application, LC-MS/MS-based applications -offering the required sensitivity-include the determination of prescription drugs or drugs of abuse. The main disadvantages of this sampling technique are the potential influence of external contamination of the skin or the sweat patches and the unknown sample volume (rendering interpretation of a quantitative result challenging), as sweat production may vary in function of physical activity or ambient temperature. Given the limited potential of sweat analysis in the routine clinical lab, the interested reader is referred to other recent reviews 23, 24 .
EBC collection only requires quiet breathing in a specially designed collection device for several minutes. Various measures can be taken to avoid EBC contamination, as recently reviewed by Konstantinidi et al. 25 . Generally, it is recommended to analyze EBC samples immediately after collection, otherwise immediate freezing, including inconvenient storage, is necessary 26 .
The collection of sputum, mucus coughed up from the lungs (after induction or not), is considered a semi-invasive sampling method. Sputum is typically -although not on a routine basis-used to investigate chronic lung diseases such as asthma, chronic obstructive pulmonary disease (COPD) and interstitial lung disease. LC-MS/MS has been used to measure a variety of analytes in sputum, amongst which leukotrienes, iso(desmosine), mucins, as well as therapeutic drugs [27] [28] [29] [30] .
Meconium, a neonate's first stool, is widely accepted as the matrix of choice for determining fetal drug exposure (other alternative matrices include umbilical cord, placenta, hair and nails 38 . In addition, a distinction has to be made between direct and indirect screening.
Direct screening examines endogenous substances, while indirect screening focusses on the conversion of substrates by specific enzymes 39 . Current NBS programs screen for up to over 50 disorders 40, 41 . Of these, 20 to over 40 disorders can be screened for by LC-MS/MS 37 .
However the exact number of disorders that is screened for varies strongly from country to country 37, 41 . A key advantage of the (LC-)MS/MS technology is that it is highly multiplexeable (e.g. a multiplex assay of lysosomal enzymes in DBS), making the procedure very attractive in routine NBS as a diagnostic platform for the early detection and confirmation of genetic disorders 42, 43 . As it is beyond the scope of this review to provide a full overview of the metabolic diseases that can be screened for by tandem MS, we refer to a comprehensive review by Lehotay et al. on this topic 37 . Furthermore, DBS can also be used at a later age, for the follow up of (treatment) of inborn errors of metabolism, as is currently applied for patients with e.g. maple syrup urine disease, phenylketonuria or tyrosinemia type 1 44 .
Endocrinology
The measurement of sex steroids, testosterone and especially estradiol, serves as a key tool in the diagnosis or management of a wide range of disorders, such as hypogonadism, polycystic ovary syndrome, amenorrhea, disorders of puberty, male and female infertility and tumors of prostate, testes, breast and ovary 45 . Sex steroid testing has known a noticeable transition from colorimetric assays using urine, over manual radio-immunoassays and automated immunoassays using serum to LC-MS/MS methods 45 . Improved precision, sensitivity and selectivity compared to automated immunoassays and the capability of multiplexing methods has resulted in substitution of traditional sex steroid immunoassays by LC-MS/MS methods in large reference clinical laboratories.
Oral fluid serves, next to plasma and serum, as a matrix for sex steroid determination.
Progress in LC-MS/MS has allowed to -at least partly-cope with the low hormone concentration, one of the challenges coupled to oral fluid analysis. However, still, sensitivity remains the limiting factor when considering e.g. the assessment of testosterone in children and women, and, to a lesser extent, in hypogonadal men via alternative sampling strategies.
Furthermore, cortisol and progesterone are also detectable in oral fluid by LC-MS/MS 46 .
Cortisol has been determined in oral fluid for the diagnosis of Cushing's syndrome and numerous stress-related disorders, as it is considered a 'stress' biomarker. Importantly, oral fluid can be used for home sampling, which can be of interest for example in the diagnosis of Cushing's syndrome, since late-night measuring of cortisol levels in oral fluid is recommended as a first-line screening test 47 . Furthermore, additional stress -which could affect cortisol test results-due to venous sampling and/or hospital visits is avoided in this way. Progesterone, a hormone that plays a pivotal role in the regulation of the menstrual cycle and in the maintenance of pregnancy, also has been measured in oral fluid, to determine luteal and placental functions in non-pregnant and pregnant women, respectively 48 . Besides oral fluid, also DBS can be used for the LC-MS/MS-based determination of steroid hormones, including corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, 21-deoxycortisol, androstenedione, testosterone, dihydrotestosterone and cortisol, although not in all cases the required sensitivity will be achievable 49 nicely demonstrated that salivary testosterone concentrations measured by LC-MS/MS are not identical to free testosterone concentrations in serum 57 . Moreover, as mentioned in section 2, pre-analytical issues, amongst which contamination of the oral fluid with blood, as well as the choice of the collection method, may have an impact on the result 58 . Hence, the decision whether oral fluid may truly serve as a more convenient and inexpensive alternative to serum/plasma for free active hormone testing may actually depend on the clinical question.
Toxicology
Alternative samples like hair and oral fluid have become an established part of toxicological investigations in many countries, with analyses being performed in both forensic and clinical labs. Although these samples can provide valuable information, their analysis is also accompanied by some challenges, as discussed in section 2. As already mentioned above (see Also the use of DBS for toxicology purposes has been advocated 6 . Samples can be obtained from adults or from newborns, e.g. to assess exposure to drugs, alcohol and other xenobiotics prior to birth. For an overview of analytes of particular forensic interest that have been measured in DBS the interested reader is referred to previous work of our group 6, 63 . The ease of (rapid) sampling and the stabilizing effect are two significant advantages coupled to DBS sampling in (forensic) toxicology. In newborn DBS, benzoylecgonine and cotinine, respectively metabolites of cocaine and nicotine, have been determined to evaluate the use of cocaine and tobacco products among childbearing woman 6 . For most applications, the limited amount of material, combined with the required sensitivity, imposes the need for a dedicated LC-MS/MS configuration. Recent progress in this field includes the set-up of hands-off online systems (see also section 5.1) 64 . When considering the cut off for driving under the influence of drugs, alcohol and medicines (DRUID), for most analytes procedures have been described that are able to achieve the required sensitivity when starting from a ≤6.4-mm DBS punch or when starting from 10 µl or less dried blood 63 . Like oral fluid, DBS may offer more convenient sample collection in the context of driving under the influence of drugs, as the usual urine sampling is coupled to privacy issues and the collection of a conventional blood sample by summoned medical staff is cumbersome and time-consuming 65 . Also in the context of driving license regranting programs, in which drivers with a history of alcohol abuse are followed up, DBS sampling may be beneficial. We recently demonstrated this for phosphatidylethanol (PEth), a direct alcohol marker that is used to monitor alcohol consumption during the past few weeks: capillary concentrations of PEth were equivalent to those found in venous blood, demonstrating that capillary DBS are a valid alternative for venous blood for this purpose 66 . Since the sampling procedure does not require dedicated staff and PEth outperforms indirect markers like carbohydrate-deficient transferrin (CDT), capillary DBS sampling offers a promising avenue for routine follow-up of drivers with a history of alcohol abuse. As is the case for CDT now, PEth determination might become a routine procedure integrated in the clinical lab. Again, LC-MS/MS is the method of choice, combining both high-throughput and sensitivity. In the toxicology lab, DBS can also be used as a sampling preparation strategy. We routinely use DBS (as well as other dried matrix spots)
for quantitative determination of gamma-and beta-hydroxybutyric acid. Although for these particular analyses we use "on-spot derivatization" and GC-MS [67] [68] [69] , the use of dried (blood, urine, …) spots as an analytical tool (also allowing automation -see section 5.1) prior to LC-MS/MS can be applied for other compounds as well 6, 70, 71 . When considering toxicology screening in an acute setting, liquid microsampling, coupled to e.g. on-line sample cleanup procedures like turbulent flow chromatography and MS/MS detection, are more likely to be used than DBS, since in most cases it would not make sense to wait for a sample to dry. Yet, it is conceivable that for screening purposes approaches like paper spray-MS/MS or -HRMS (see further in section 6.4) might be employed in future, to get an instant identification of an intoxicant. Again, a drop of blood might suffice.
Over the last years, meconium has proven to be a valuable matrix in the assessment of prenatal exposure to drugs of abuse and has gained a lot of interest due to the higher sensitivity, the easier sample collection and the larger detection window than traditional matrices, such as neonatal hair and urine 32 . To date, effort has been put in the development of Furthermore, the use of other non-invasive matrices in toxicology, such as nails, sweat and breast milk, has been enabled by the introduction of sensitive analytical techniques. Although these matrices can be useful in some instances (e.g. doping control, determination of exposure to environmental contaminants), their more widespread implementation in clinical routine is less likely, given the specialized nature of these samples.
TDM
TDM serves as an excellent tool in the optimization and individualization of drug therapy in both the general and special populations. Most often, TDM is performed on venous blood samples (whole blood, plasma or serum). Unfortunately, these samples are collected in an invasive way and the amounts of blood that are required are relatively large for e.g. neonates or anemic patients. In addition, samples need to be obtained by a phlebotomist, which obliges patients to visit a hospital or doctor's office for a blood draw. Therefore, there is a growing interest in the use of non-and minimally invasive alternative sampling strategies for TDM.
The most widely used alternative matrix in this regard is DBS 4, 5 . The use of DBS for TDM offers several benefits. As DBS are mostly obtained by a finger prick, the patient himself can perform the finger prick at home. In addition, as DBS are considered non-contagious, they can be sent via regular mail to the clinical laboratory 5 . This way, laboratory results may already be available before a patient visits the clinician for routine follow-up. However, the small sample size (typically 3 -12 µL) associated with DBS imposes the need for sensitive instrumentation 5 . This need can generally be met with LC-MS/MS. Whereas throughput can be considered a limitation of DBS analysis -at least when considering manual handling of DBS -the emergence of automated DBS analyzers could be of great benefit for clinical routine, as outlined further (see section 5.1). 89 . Outside the hospital, TDM may also play a crucial role in assessing patient adherence to prescription regimens of medication, as patient nonadherence is a worldwide problem and leads to serious consequences (e.g. additional use of scarce healthcare sources and higher costs of care, negative impact on the efficacy of treatments and patient's wellbeing) 90 . In this context, TDM via DBS also fits within the concept of "precision medicine", where a patient should not only get the right drug, but also at the right dosage to achieve the right concentration, eventually leading to optimized medication usage.
Although the small sample volume is one of the main advantages of DBS, it can be a limiting factor in certain cases as well, e.g. when a physician wants to evaluate various parameters in the same blood sample during treatment follow-up. The simultaneous determination of the kidney function, for example, can be of great importance given the fact that many drugs are excreted by the kidneys and/or may cause renal failure. In this case, creatinine (endogenous)
or iohexol (administered) can be determined to assess the glomerular filtration rate. Koster et al. recently developed an LC-MS/MS method for the combined analysis of creatinine and several immunosuppressants in the same DBS extract, which is of great importance given the risk of renal failure associated with immunosuppressant use 91 . Since iohexol, a contrast agent, has already been analyzed in DBS, its determination in a DBS together with a drug of interest appears another feasible future perspective 92 . In summary, DBS can offer a lot of advantages in the context of TDM. However, the choice to switch from traditional sampling to DBS sampling needs to be well-balanced, taking into account the clinical question and the context in which both sampling and analysis need to take place.
Another alternative matrix which has been extensively evaluated in the context of TDM is oral fluid. Since oral fluid is often regarded as a natural ultrafiltrate of whole blood, its use has been advocated as a convenient alternative to ultrafiltration or equilibrium dialysis to assess the free concentrations of therapeutic drugs 93 . In addition, oral fluid has the advantage of being obtained in a non-invasive manner, yielding the possibility of home sampling.
Obviously, the latter is only feasible when a compound is sufficiently stable under ambient conditions, which needs to be evaluated during method development and validation. The stability of newer anti-epileptic drugs, for example, has proven to be adequate, allowing samples to be sent to the laboratory via postal service 94 . Furthermore, preservatives can be added to collection devices to enhance analyte stability 95 .
Although oral fluid levels are suggested to correlate with the plasma free fraction of a drug, a correlation between both (or between oral fluid levels and total plasma levels) is often lacking. Moreover, even when a correlation is observed, the latter might be time-or concentration dependent and/or intra-and interpatient variability may be too large to allow reliable use in clinical practice 17 . Therefore, oral fluid is probably not suitable for TDM of most therapeutic drugs 96 . Generally, non-ionizable drugs (at least within the pH range of oral fluid) are considered the best candidates 10, 16 . However, this always needs to be evaluated on a case-by-case basis. Antiepileptics are one of the drug classes for which oral fluid-based TDM can be performed successfully. Specific antiepileptic drugs for which oral fluid provides a good alternative include carbamazepine, clobazam, ethosuximide, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, phenobarbital, phenytoin, primidone, topiramate, and zonisamide. For valproic acid on the other hand, this approach is not useful 12 .
Additionally, also other alternative matrices such as tears, hair, sweat, exhaled breath and ISF have been evaluated for TDM purposes. Although some of these (e.g. ISF sampling via microneedles 34 ) seem promising, currently, their use in routine TDM laboratories is nonexisting or limited at best.
Phenotyping
Phenotyping aims at determining the exact actual enzymatic activity of Cytochrome P (CYP) 450 enzymes. In general, phenotyping for a drug-metabolizing enzyme consists of administering a selective probe drug of the enzyme, followed by determining a specific pharmacokinetic metric (e.g. systemic clearance of the probe drug, single-point concentrations or metabolite/parent drug concentration ratios) 97 . CYP450 enzymes mainly catalyze phase I metabolism reactions, the first step in the enzymatic biotransformation which is chiefly responsible for the elimination of drugs and other xenobiotics. Interindividual variability is seen in CYP450 enzyme expression and function, which is determined by genetic, epigenetic and non-genetic host factors (e.g. sex, age, pathophysiological conditions) and by environmental influences, such as tobacco smoke, drug intake and diet enzymes, including CYP1A2, CYP2C19 and CYP2D6 are available using alternative sampling strategies. For CYP3A4 on the other hand, additional studies are necessary 97 . For more details, the interested reader is referred to the recent comprehensive review by De Kesel et al. 97 .
Metabolomics, proteomics and protein analysis
The use of alternative sampling strategies in the 'omics' arena is to date limited to DBS, oral fluid and EBC. In a clinical setting, metabolomics and proteomics are typically targeted approaches, following a discovery phase in which a selected set of biomarkers (proteins and small molecules, respectively) has been identified. 
LIMITING FACTORS
Although the use of alternative sampling strategies may be appealing for certain applications, their use in clinical routine is hampered by some practical hurdles, technical challenges and inherent (minor) disadvantages. First of all, the development of methods using alternative matrices generally takes longer, since more variables need to be evaluated. Examples include the evaluation of hematocrit, volume and chromatographic effect in DBS analysis and the influence of the collection method and collection device used in oral fluid analysis. In addition, method development may be further complicated due to interferences originating from e.g. DBS filter paper or oral fluid collection devices 18, 114 . Unfortunately, the abovementioned additional variables are often not included in standard validation guidelines and matrix-specific guidelines are not always available. 116 . In DBS analysis on the other hand, the hematocrit effect is the most prominent issue affecting data accuracy and interpretation 3 . Another practical issue in interpreting DBS results is the fact that existing reference intervals and therapeutic ranges are generally established using serum or plasma. So either new reference intervals need to be set up for the specific matrix or bridging studies have to be conducted to correlate alternative matrix levels to systemic plasma or serum levels, whenever a correlation between both is assumed 117 . However, thorough clinical validation is often lacking, as generally only a limited number of samples are included in these studies or the included samples are not true patient samples. In addition, studies on the effect of the use of alternative matrix analysis on patient outcome have not been conducted to the best of our knowledge.
Moreover, as mentioned above, the analysis of alternative matrices requires sensitive equipment, since only a limited sample volume may be available and/or concentrations present may be very low. Hence, when obtaining sufficient sensitivity using traditional matrices (e.g. 100 µL of plasma) is already challenging, analysis of a DBS, for example, may not be feasible. Furthermore, the analysis of alternative matrices such as DBS and hair often includes a lot of manual steps and hands-on time, limiting sample throughput and increasing turn-around-time. Also the set-up of a quality control (QC) program is particularly challenging for alternative matrices (as outlined in section 5.2). Furthermore, it needs to be taken into account that in the case of home sampling of e.g. DBS or oral fluid there is no control of sample collection and storage conditions, as the collection is carried out by the patient or his caregiver, instead of by trained personnel. Although the collection of these samples is not that hard, quality issues with patient samples may pose problems. Also important in a clinical setting is the fact that these alternative tests may not be included in nomenclature and hence may not be reimbursed by the public healthcare system.
TOWARDS ROUTINE IMPLEMENTATION
To overcome the above-mentioned hurdles a lot of work has been done and is still ongoing, including the development of new, sensitive and robust analysis techniques, new sampling formats, automated analyzers, and a surrounding support system comprising e.g. proficiency testing (PT) programs and matrix-specific best practice guidelines.
Automation
An important step in incorporating the analysis of alternative samples in routine laboratories is automation; not only to increase throughput and safety, but also to decrease hands-on time and to exclude human errors. Ideally, automation encompasses the pre-analytical, analytical and post-analytical phase. More specifically in the case of DBS or DPS, this means a lab technician would only have to introduce a patient's card into an analyzer after which the sample is automatically analyzed and the obtained result communicated into a laboratory management information system. Promising advancements have been made in this regard.
The tedious punching step can be replaced by (semi-)automated punching devices, whilst sample preparation can be automated using e.g. readily available liquid handling systems 118 .
Furthermore, completely automated DBS/DPS analyzers have become commercially available and can be directly coupled to standard LC-MS/MS configurations. These analyzers have accessories such as e.g. barcode readers that allow for sample registration and traceability.
Every type of DBS/DPS automated analyzer uses solvents to elute a fixed area of matrix from a collection card, obviating the need for punching. The way the elution is performed depends on the type of analyzer: the DBS Autosampler TM and the Sample Card and Prep system TM both employ flow through desorption, whilst in the DBS-MS 500 system extraction solvent is guided horizontally through the DBS during a surface sealed extraction, after which the extract is guided into a sample loop [119] [120] [121] . After elution, the extract can be subjected to on-line sample clean-up and/or separation on an LC column or even direct injection into the MS, depending on the chosen configuration 8, 64, [119] [120] [121] . Importantly, using automated DBS analyzers, the entire DBS extract is introduced into the (LC-)MS/MS system, thereby increasing method sensitivity, since in off-line approaches only part of the extract is injected into the analyzing system. The DBS-MS 500 system is currently the only analyzer in which internal standard can be sprayed onto the DBS before extraction 119 . In the two other types of analyzers the internal standard is automatically added to the elution solvent. To verify whether the correct portion of the card has been analyzed these analyzers can take a picture of the sample before and after analysis. In addition, it is also possible to use the DBS analyzers as automated sample preparation devices that are not coupled to an LC-MS/MS system. To reduce hands-on-time even further, also the preparation and spotting (in the case of DBS/DPS) of calibrators, QCs and blanks can be automated using a commercially available liquid handling system 59, 122 . This procedure showed similar accuracy and precision as manual preparation, but was safer, more efficient and yielded samples of predictable quality.
Also for the analysis of other alternative matrices, automation is important to allow convenient implementation in a routine setting. Therefore, commercially available workstations can be employed to automate laborious sample pretreatment steps as much as possible. This was e.g. done for the analysis of drugs of abuse in preserved oral fluid samples collected using Quantisal TM devices 59 . For this application the workstation was not only used for IS addition, but also for automated SPE. The only remaining manual step during sample pretreatment was the evaporation of the SPE eluate which was automatically collected in LC vials. However, for some matrices automation may prove challenging. In the case of hair analysis for example, the inability to handle the solid hair sample limits the degree of potential automation 123 .
Importantly, when using LC-MS/MS in a routine setting, not only the sample handling and the on-line sample preparation need to be automated, also the LC-MS/MS modules and software programs should become more user-friendly. More specifically, to make LC-MS/MS technology as convenient as possible for lab technicians, ideally a sort of "black box" LC-MS/MS unit should be integrated in existing chemistry analyzers. One suggestion that has been made in this regard is the development of an analyzing module with hybrid technology combining the characteristics of immunoassays and tandem MS 124 , potentially omitting the need for LC.
Another, complementary way of increasing throughput to which LC-MS/MS lends itself perfectly, is to multiplex different analytes in a single run. The latter also aids in retrieving as much information as possible from a limited sample. However, in hair analysis the development of such multi-analyte procedures might prove challenging, since authentic hair samples are required for e.g. extraction optimization during method development 123 .
Additionally, multiple LC systems can be multiplexed on one MS, further allowing a more economic use of the MS. This can be via staggered analysis (in which the chromatographic eluate only enters the MS/MS system during the time window where the compounds of interest elute) and/or via a more convenient switching between different methods, since no hardware changes need to be performed. Even sample multiplexing (i.e. the simultaneous introduction of two samples that were differentially derivatized) may be considered an option to increase throughput 125 . 131 . Therefore, to facilitate these types of programs, harmonization/standardization will be important in the future.
Quality assurance and harmonization
Not only the analytical method itself, but also the patient samples (even when collected at home) have to be of sufficient quality. A first step towards achieving this is by guaranteeing the quality of the substrate on which the sample is collected. For DBS sampling this is achieved via the Filter Paper Evaluation Project, set up by the center for disease control and prevention (CDC) which also offers its services to filter paper manufacturers 130 . The quality criteria postulated by the CDC resulted in the laboratory standard, Clinical and Laboratory
Standards Institute NBS01-A6, which has greatly contributed to the reduction of analytical imprecision due to batch-to-batch variability in filter paper. Furthermore, the quality of a DBS is also evaluated before analysis, either by experienced laboratory personnel or in an automated fashion using an optical scanning instrument 132 . Such instruments objectively evaluate spot area, circularity, convexity and consistency (i.e. DBS size, symmetry and uniformity). In this way, acceptable, marginally acceptable, and unacceptable DBS are distinguished and acceptable punch areas identified. To maximize the amount of acceptable spots in the event of home sampling, patient education via demonstration folders and movies has proven to be essential. To evaluate whether contamination occurred during sample collection, incurred sample reanalysis or analysis of a blank filter paper area close to the DBS has been advocated 6, 133 . Also for other matrices which are usable for home monitoring, evaluation of sample quality is essential. Therefore, it can for example be advised to perform oral fluid home sampling using collection devices with volume indicators.
To help harmonization and standardization of alternative matrix analysis, best practice guidelines have been proposed by several committees (e.g. SoHT or the European Bioanalysis Forum consortium) highlighting important pitfalls and validation requirements 116, 128 . Also harmonization of data interpretation is an essential goal of these committees. The SoHT and the DRUID project, for example, have played an important role in the determination of cutoffs for toxicological analysis of hair and oral fluid, respectively 116, 134 . 141 . Unfortunately, also DPS appear to be subject to a certain hematocrit effect 141 . A third possibility is to estimate the hematocrit of a DBS and to correct for the anticipated hematocrit effect 142 . Recently, we developed a non-contact hematocrit estimation method (Capiau et al., unpublished data) which could potentially be more easily automated than the potassium-based hematocrit estimation method we previously established 7 .
FUTURE TRENDS

Development of new formats
Also for other alternative matrices innovation is ongoing. An example is the development of a new exhaled breath collection device for the analysis of drugs of abuse, which allows to standardize the volume of matrix collected (at least to some degree) and facilitates remote collection by non-trained personnel 143 . The device is composed of a filter which is located in a filter holder and a mouth piece which is attached to a plastic bag. When a person breathes into the device, aerosol particles will be collected onto the filter and the plastic bag will inflate.
When the plastic bag is full, sufficient matrix has been collected onto the filter. Subsequently, the filter holder and the mouthpiece can be detached from one another and the filter holder can be closed with plugs and sent to a laboratory via regular mail.
Microfluidics
Microfluidics have been employed for alternative matrix collection and sample preparation in conjunction with tandem MS. One example includes the use of a lab-on-a-chip for sample preparation of either a DBS punch or a directly applied capillary blood droplet 144 
High resolution mass spectrometry (HRMS)
Aside from its use in e.g. biomarker discovery research (possibly in oral fluid or DBS), untargeted screening using HRMS is increasingly becoming a valuable tool for toxicological purposes, e.g. allowing detection of new psychoactive compounds and their metabolites 
MS(/MS)-based point-of-care testing (POC)
Another important trend in clinical analysis is the development of MS(/MS)-based POC testing and/or near-patient analysis. The latter may be performed at a professional healthcare center, at the emergency unit or even in operating theatres. However, development of these decentralized analyses is most often -and ideally-still under the supervision of the clinical laboratory, which is responsible for e.g. quality assurance. In general, these POC techniques do not require sample preparation steps nor a separation step and employ ambient ionization techniques (although a multitude of ambient ionization techniques have been employed, selected examples will be discussed). In this context as well, alternative sampling strategies have been employed. Examples include the use of paper spray MS for the analysis of blood or oral fluid collected on filter paper for e.g. TDM purposes and abstinence monitoring 152, 153 . In paper spray MS, a drop of the biological sample is deposited on a triangle-shaped filter paper which is part of a disposable collection cartridge. After the cartridge has been positioned in front of the MS, a solvent is applied to the filter paper, as well as a high voltage. This causes a spray to be formed at the tip of the triangle, which is then transmitted into the MS.
Subsequently, the resulting signal is recorded for a fixed period of time, which results in a signal vs. time plot (called a chronogram). To quantify the amount of the target compound present, the area under the curve of this chronogram is employed. To be workable in a POCsetting, the blood on the filter paper is either analyzed when it is still wet or after it has been quickly dried using either pre-spotted coagulants or heat application [152] [153] [154] . A first step towards automation has been accomplished by the development of a tray, which can hold multiple filter paper triangles which are consecutively analyzed 155 . In addition, to render POC-MS feasible, portable MS systems have been developed 156 . The mini 12, for example, has been employed for the analysis of the therapeutic drug amitriptyline using paper spray MS 157 . The goal of this instrument is to be able to offer a sample to a miniature MS after which analysis and data analysis are performed automatically and a result is directly generated on the screen.
Similarly, the concept of touch spray MS has been developed. This refers to the direct analysis of oral fluid collected on a medical swab. In this case as well, a solvent and a voltage are applied to the collection device after which a spray is formed. Applications of the technique include the semi-quantification of various drugs and the detection of lipids which are specific to S. pyogenes to quickly diagnose strep throat 158, 159 . In addition, even surgical smoke has been sampled via a surgical knife to help differentiate between cancerous and noncancerous tissue during surgery 160 .
CONCLUSION
Although ample clinically valuable applications have been developed using alternative sampling strategies, their adoption in routine clinical laboratories is still limited. Aside from the vast use of DBS in NBS programs, only few examples can be found which employ alternative sampling strategies for routine analyses using LC-MS/MS. Examples include the determination of salivary cortisol levels, the determination of drugs of abuse in oral fluid, and the use of DBS for TDM purposes. The growing automation of alternative matrix analysis will definitely contribute to the acceptance and introduction in routine practice. In addition, matrix-dependent issues are (successfully) being tackled and new, more robust formats are being developed, bridging the gap between research and clinical laboratories. To guarantee the quality of alternative matrix-based assays, initiatives to set up guidelines for the development and validation of these assays (which take into account matrix-specific requirements) as well as matrix-specific PT programs are essential. Although alternative sampling strategies will never replace traditional sampling, they should definitely be regarded as a complementary approach, which may be particularly valuable to extend the window of detection and/or to allow specific applications such as home monitoring, sampling of special patient populations (such as neonates, children and elderly), and sample collection in remote or resource limited areas. In this context, alternative sampling strategies, combined with LC-MS/MS, can be looked at as an additional tool, with the potential to provide high quality results where adequate information cannot be (conveniently) obtained using traditional approaches. 
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